Pharmacological inhibition on the ataxia telangiectasia and Rad3-relevant protein serine/threonine kinase (ATR; also referred to as FRAP-related protein (FRP1)) has emerged like a promising technique for cancer cure that exploits synthetic lethal interactions with proteins associated with DNA harm maintenance, overcomes resistance to other therapies and improves antitumour immunity. M... https://hansr998dpz1.actoblog.com/profile